TRATAMIENTOS APLICADOS EN PACIENTES POR INFECCIÓN DE COVID-19 CON DIABETES MELLITUS TIPO 2

Abstract

Coronaviruses are RNA viruses that cause different types of respiratory illnesses. At the end of 2019, a new coronavirus was identified and declared a pandemic on March 11, 2020. There is the development of diabetes in patients with SARS-CoV-2, so it is possible that it could cause alterations in glucose metabolism leading to the development of diabetes mellitus. The objectives of article to carry out a bibliographic review of the treatments applied in patients infected with Covid-19 and who have type 2 diabetes mellitus as their underlying pathology. The results this investigation all the articles analyzed describe the use of metformin, insulin and corticosteroids as the mainstay of treatment, accompanied by patient education and communication between health personnel and the patient. Conclusion treatment is based on the patient's usual medication, but with slight adjustments depending on glucose control. Different treatments have also been described such as incretins, ACE inhibitors, chloroquine and hydroxychloroquine and SGLT2 inhibitors among others that have acted in different ways to control this pathology.